Locations:
Search IconSearch
August 31, 2023/Cancer/News & Insight

CME Program Takes Multidisciplinary Approach to Colorectal Cancer

Case-based course delves into latest treatment approaches

23-CNR-4185077-CQD-Hero-650×450

Emerging diagnostics, therapies and procedures are improving the outlook for patients with colorectal cancer, yet this rapidly changing treatment landscape can be confusing. Similarly, healthcare providers are confounded by high rates of colorectal cancer in patients under the age of 50. The 9th annual colorectal oncology course, held at Marco Island, Florida on October 6-7, 2023, will feature panel discussions and Q&As with noted specialists across surgery, radiation oncology and genomics managing this complex disease.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“This essential update on the latest treatment changes in colorectal cancer will provide a multidisciplinary approach that’s crucial for disease management,” says Alok Khorana, MD, Director, Gastrointestinal Malignancies Program at Cleveland Clinic Cancer Center. “The program also brings focus to diagnosing and treating young-onset colorectal cancer.”

This two-day program is ideal for oncologists, surgeons, radiation oncologists, nurses and other healthcare professionals with an interest in treating patients with colorectal cancer. “For clinicians who may be too busy to attend large conferences, this national symposium a convenient way to get up to speed on everything that’s new in treating this disease.”

In this in-depth symposium, learners will gain a detailed look at a wide range of topics, including:

  • Total neoadjuvant therapy and neoadjuvant chemotherapy
  • The role of genomics and circulating tumor DNA in treatment decisions
  • Patient case studies
  • Management disease recurrence and adverse events

The live event is designated for a maximum of 8.25 American Medical Association PRA Category 1 Credits™ and 8.25 American Nurses Credentialing Center contact hours.

Register now.

Advertisement

Related Articles

Doctors working on MGUS screening study
March 18, 2024/Cancer/Research
Pilot Study Aims for Early Identification of Multiple Myeloma Precursor Among Black Patients

First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses

Hematologist at Cleveland Clinic
March 14, 2024/Cancer/Blood Cancers
Advances in Mantle Cell Lymphoma Treatment (Podcast)

Global R&D efforts expanding first-line and relapse therapy options for patients

Physician with patient
March 6, 2024/Cancer/Research
Targeting Uncontrolled Erythrocytosis in Polycythemia Vera with Rusfertide

Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels

Dr. Jagadeesh at Cleveland Clinic
February 28, 2024/Cancer/Blood Cancers
Treating Patient with Systemic T-Cell Lymphoma and Graft-Versus-Host Disease

A case study on the value of access to novel therapies through clinical trials

Doctor measuring patient's waist size
February 26, 2024/Cancer/Research
Impact of Obesity on GVHD & Transplant Outcomes in Hematologic Malignancies

Findings highlight an association between obesity and an increased incidence of moderate-severe disease

Physician with patient
February 21, 2024/Cancer/Research
Strategies for Improving Clinical Trial Equity

Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456

How antibody drug conjugates work
February 13, 2024/Cancer/Research
Real-World Use of Trastuzumab Deruxtecan

Key learnings from DESTINY trials

CQD-4445459-rotz-650×450
February 7, 2024/Cancer
Advances in Bone Marrow Transplant Have Improved Outcomes in Fanconi Anemia

Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients

Ad